Current Drug Metabolism (ISSN 1389-2002) is a peer-reviewed international journal published by Bentham Science Publishers in the United Arab Emirates, dedicated to advancing the understanding of drug metabolism and its clinical implications. Appearing on a monthly basis, the journal serves as a specialized forum for researchers investigating pharmacokinetics, drug-drug interactions, enzyme kinetics, and transporter biology, with a particular emphasis on elucidating metabolic mechanisms during new drug development and bridging preclinical findings with clinical applications. As a non-open access publication indexed in the Science Citation Index (SCI), it maintains an impact factor typically ranging between 2 and 3, positioning it within the third or fourth quartile of the Chinese Academy of Sciences journal rankings for pharmacy and biochemistry fields. While the journal holds established recognition within the niche field of drug metabolism, authors are advised to consider its moderate impact factor and potentially extended review timelines, as well as the broader context of the publisher’s academic standing, when selecting a venue for their work. Consequently, it remains a suitable outlet for scholars focused on specific aspects of metabolic science who prioritize disciplinary relevance alongside a balanced assessment of the journal’s overall academic influence.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com